Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Caneman Consulting AB
AB
Active
Org 5594073818
Höglandsvägen 42
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 40K
-59% vs 2023
EBITDA margin
-55.9%
-125% vs 2023
Equity ratio
70.3%
Financial strength
Net profit 2024
SEK -22K
-129% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 40K
-59%
EBITDA
SEK -23K
-125%
Net profit
SEK -22K
-129%
Total assets
SEK 110K
-25%
Equity
SEK 77K
-22%
Employees
0
—
Company information
Legal name
Caneman Consulting AB
Org number
5594073818
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22 november 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska importera, producera och sälja kognitiva tester.
Contact
Address
Höglandsvägen 42
Email
maria.caneman@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Täby
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
98
40
Staff expenses
—
—
EBITDA
92
−23
Depreciation & amort.
—
—
EBIT
92
−23
Net financials
1
1
Profit before tax
93
−22
Tax
−20
—
Net profit
74
−22
Balance sheet
SEK thousands
Item
2023
2024
Total assets
146
110
Equity
99
77
Long-term debt
—
—
Short-term debt
48
33
Total debt
48
33
Financial ratios
5-year trend
EBITDA margin
-55.9%
This company
15.8%
Market median
-454% vs market
2023
2024
Equity ratio
70.3%
This company
38.2%
Market median
+84% vs market
2023
2024
Return on equity
-28.2%
This company
18.4%
Market median
-253% vs market
2023
2024
Net profit margin
-53.7%
This company
8.1%
Market median
-763% vs market
2023
2024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
2023
2024
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-11-22 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
ME
Maria Eleonora Caneman
Board of Directors
2022
AM
Anders Mattias P Caneman
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Caneman Consulting AB also hold positions in
0
other companies.
Person
Role here
Other companies
Maria Eleonora Caneman
Board of Directors
0 companies
Anders Mattias P Caneman
Deputy Board Member
0 companies